StonvexLoading…
StonvexCore line items from CVE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$49.70B | C$54.28B | C$52.20B | C$66.90B |
Operating Income | C$4.48B | C$4.07B | C$5.04B | C$8.73B |
Net Income | C$3.93B | C$3.14B | C$4.11B | C$6.45B |
EPS (Diluted) | C$2.15 | C$1.67 | C$2.09 | C$3.20 |
Total Assets | C$63.42B | C$56.54B | C$53.91B | C$55.87B |
Total Liabilities | C$31.79B | C$26.77B | C$25.20B | C$28.28B |
Cash & Equivalents | C$2.74B | C$3.09B | C$2.23B | C$4.52B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |